Balyasny Asset Management »

Seelos Therapeutics Ord shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Seelos Therapeutics Ord (SEEL) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Seelos Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Ord held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Ord by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $224k 379k 0.59
2023-12-31 $368k 265k 1.39

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Apple (AAPL)
Select Sector Spdr Tr Financial (XLF)
Pioneer Natural Resources Put Option (PXD)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
JPMorgan Chase & Co. Call Option (JPM)
Hess Call Option (HES)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom Call Option (AVGO)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Asml Holding N V N Y Registry Shs Call Option (ASML)

View all positions for Balyasny Asset Management

Top funds holding Seelos Therapeutics Ord

Wealth Effects
AdvisorShares Investments
Jeffrey L. Gendell
Balyasny Asset Management
Vanguard Group
Modera Wealth Management
Morgan Stanley
Geode Capital Management
BlackRock
Strategic Family Wealth Counselors
Jane Street
XTX Topco
Two Sigma Investments
CRA Financial Services
Tower Research Capital

View all funds holding Seelos Therapeutics Ord